Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Roche integrates diabetes app with Apple Health

Accu-Chek Connect will allow patients to share data with the iPhone system

Roche Diabetes Care Accu-Check 

Roche Diabetes Care's Accu-Chek Connect will now allow patients to share the blood glucose and carbohydrate data they collect with the iPhone's Apple Health app.

The integration of Accu-Chek with Apple's HealthKit software means that, with user permission, Accu-Chek Connect could also integrate with other HealthKit-enabled apps, such as electronic medical record or health tracker apps.

Marc Gibeley, head of Roche Diabetes Care North America, said: “For people with diabetes, simplifying the management of their condition can be an essential part of championing their own health and wellness.

“This integration is the next step in helping those with diabetes adopt a holistic approach in managing their overall care, by allowing them to log, view, and share their diabetes data with other health tracking applications on their iPhone. It also provides healthcare teams with a better view of the patient's lifestyle as they assess the role of health and fitness in their management routine.”

The Accu-Chek Connect diabetes management system that consists of the Accu-Chek Aviva Connect meter, an app and an online portal that allows patients, caregivers, and healthcare providers to view and share blood glucose data.

The meter wirelessly sends blood glucose results to the Accu-Chek Connect iPhone app, which also has an insulin dosage calculator that doctors can activate.

18th March 2016

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics